Keywords: China, OTC markets, Rx-to-OTC switches, Opportunities, Kline & Co

Rx switches among factors that will push China's $32 billion OTC market higher

Article | 28 November 2012

With vigorous 15% growth over the previous year and a confluence of factors encouraging even greater growth, the Chinese over-the-counter (OTC) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in